FIELD: medicine, pharmacy. SUBSTANCE: invention proposes ointment for treatment of suppurative-necrotic processes. Agent has the following components, wt.-%: of loxacin 0.05-0.50; trimecain or lidocaine 1.00-6.00; protease C 0.50-3.00; proxanol-268 15-25; propylene glycol 25.0-78.4; polyethylene oxide-400 5-20 and purified water - the rest up to 100. Agent shows the complex effect on damaged zones and ensures to reach the high level of multidirected specific activity at simultaneous decrease or elimination of negative adverse effects. EFFECT: enhanced effectiveness of agent. 8 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
| ANTIBACTERIAL AND NECROLYTIC LOCAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367456C2 |
| ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
| AGENT FOR INFECTED WOUND TREATMENT | 1991 |
|
RU2020934C1 |
| COMBINED ANTIMICROBIAL AGENT FOR TREATMENT OF FOUL WOUNDS | 2004 |
|
RU2283088C2 |
| COMPOSITION FOR TREATMENT OF SUPPURATIVE-NECROTIC WOUNDS (VARIANTS) | 1997 |
|
RU2150936C1 |
